My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Traws Pharma, Inc. - Common Stock (NQ:TRAW)

2.950 +0.050 (+1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 195,310
Open 2.890
Bid (Size) 2.840 (4)
Ask (Size) 2.990 (2)
Prev. Close 2.900
Today's Range 2.700 - 2.960
52wk Range 0.9700 - 19.44
Shares Outstanding 5,564,315
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
From Traws Pharma, Inc.
Via GlobeNewswire

Performance

YTD
-66.0%
-66.0%
1 Month
+42.5%
+42.5%
3 Month
+99.3%
+99.3%
6 Month
+38.5%
+38.5%
1 Year
-41.1%
-41.1%

More News

Read More
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Appoints Mark Guerin as Chief Financial Officer
Via Investor Brand Network
Earnings Scheduled For August 14, 2025
Via Benzinga
Annovis Appoints Mark Guerin as Chief Financial Officer
From Annovis Bio Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
From Traws Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Traws Pharma Posts Q2 Revenue Jump
Via The Motley Fool
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
Via Stocktwits
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
From Traws Pharma, Inc.
Via GlobeNewswire
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!
Via AB Newswire
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Dow Gains Over 100 Points; US Job Openings Increase In April
Via Benzinga
Topics Stocks
Tuesday's session: gap up and gap down stocks
Via Chartmill
US Stocks Mixed; Dollar General Posts Upbeat Earnings
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
From Traws Pharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Traws Pharma, Inc. - Common Stock publicly traded?
Yes, Traws Pharma, Inc. - Common Stock is publicly traded.
What exchange does Traws Pharma, Inc. - Common Stock trade on?
Traws Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Traws Pharma, Inc. - Common Stock?
The ticker symbol for Traws Pharma, Inc. - Common Stock is TRAW on the Nasdaq Stock Market
What is the current price of Traws Pharma, Inc. - Common Stock?
The current price of Traws Pharma, Inc. - Common Stock is 2.950
When was Traws Pharma, Inc. - Common Stock last traded?
The last trade of Traws Pharma, Inc. - Common Stock was at 10/14/25 04:00 PM ET
What is the market capitalization of Traws Pharma, Inc. - Common Stock?
The market capitalization of Traws Pharma, Inc. - Common Stock is 16.41M
How many shares of Traws Pharma, Inc. - Common Stock are outstanding?
Traws Pharma, Inc. - Common Stock has 16M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.